Publication date: January 2027 Source: European Neuropsychopharmacology, Volume 114 Author(s): K. Kleine Schaars, S. Bedi, Kristian Kleine Schaars, Sanah Bedi, Janet Strozeski, Allan H. Young, Mario Juruena, Daniel Silman, Urs Heilbronner, Monika Budde, Alba Navarro-Flores, Magnus Ingelman-Sundberg, Marin Jukic, Martien J.H. Kas, Raj Jagesar, Andra Ciucă, Ramona Moldovan, Markus M. Nöthen, Per Hoffmann, Carina M. Mathey
Age and sex related differences on genotype stratified CYP450 mediated metabolism rate in healthy populations; a systematic review. // European Neuropsychopharmacology. – URL: https://www.sciencedirect.com/science/article/pii/S0924977X26011417?dgcid=rss_sd_all
Age and sex related differences on genotype stratified CYP450 mediated metabolism rate in healthy populations; a systematic review. European Neuropsychopharmacology. https://www.sciencedirect.com/science/article/pii/S0924977X26011417?dgcid=rss_sd_all
“Age and sex related differences on genotype stratified CYP450 mediated metabolism rate in healthy populations; a systematic review.” European Neuropsychopharmacology.
@article{article107476,
title = {Age and sex related differences on genotype stratified CYP450 mediated metabolism rate in healthy populations; a systematic review},
journal = {European Neuropsychopharmacology},
url = {https://www.sciencedirect.com/science/article/pii/S0924977X26011417?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...